Our scientists are relentless in their pursuit of raising the standards of care within neuroscience. See how our team approaches understanding the complexities of the brain, tackling new challenges that require new ways of thinking across all stages of drug discovery and development.
See how AbbVie is creating a better workplace for people with migraine, the second-most disabling condition in the world.
The ongoing search for an answer sparked this doctor’s decades-long career in neurodegenerative disease research.
One billion people impacted. Millions of workdays missed. Countless events skipped. The toll of migraine adds up. But so does progress in care.
Prompt action is key to combat post-stroke spasticity. Researchers are trying to raise visibility of the condition to help people recognize it early.
One patient faces the progression of Alzheimer’s disease through family, positivity and supporting research.
The product-specific site Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals that are not approved in other countries or region. If you are a resident of a country other than those to which the site is directed, please return to AbbVie.com or contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence. The Internet site that you have requested may not be optimized to your screen size. Do you wish to continue to this product-specific site?